株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

乳房インプラント市場 - 成長、傾向、および予測(2019年 - 2024年)

Breast Implant Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 871411
出版日 ページ情報 英文 115 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
乳房インプラント市場 - 成長、傾向、および予測(2019年 - 2024年) Breast Implant Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年05月01日 ページ情報: 英文 115 Pages
概要

当レポートでは世界の乳房インプラント市場について調査しており、市場概況や成長要因・阻害要因、タイプ・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報をまとめています。

目次

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 乳がんの発生率の上昇
    • 豊胸手術件数の増加
    • 技術の進歩
  • 市場の阻害要因
    • 乳房インプラントの合併症とそれに関連するリスク
    • 高コスト
  • ポーターファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • タイプ別
    • シリコーンインプラント
    • 形状安定インプラント
    • 生理食塩水インプラント
    • 構造化生理食塩水インプラント
  • 用途別
    • 再建手術
    • 美容整形
  • エンドユーザー別
    • 病院
    • 美容クリニック
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Allergan PLC
    • Establishment Labs SA
    • GC Aesthetics
    • Groupe Sebbin SAS
    • Laboratories Arion
    • Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson)
    • POLYTECH Health & Aesthetics GmbH
    • Shanghai Kangning Medical Supplies Ltd
    • Sientra Inc.

第7章 市場機会および今後の動向

目次
Product Code: 64745

Market Overview

The major factors for the growth of the breast implant market include the rising incidence of breast cancer, an increasing number of breast augmentation procedures, and technological advancements.

Breast cancer is currently the leading cause of cancer-related deaths in women in the world's developing regions. According to the National Cancer Institute, an estimated 252,710 women have been diagnosed with breast cancer in 2017. Furthermore, 230,815 American women were diagnosed with breast cancer in 2013. Over 3.1 million American women have been affected by breast cancer as of March 2017. According to the American Cancer Society, in 2017, an estimated 252,710 new cases of invasive breast cancer were diagnosed among women. In addition, 63,410 cases of in situ breast carcinoma were diagnosed among women. Approximately 40,610 women and 460 men died from breast cancer in 2017 and therefore, the number of breast cancer cases are expected to increase in the coming years. According to the Cancer Research UK, there are around 54,900 new breast cancer cases in the United Kingdom every year, that is around 150 per day (2013-2015). Moreover, it is estimated that the risk of an individual dying from breast cancer would increase in the coming years. Hence, the increase in breast cancer prevalence is a major factor contributing to revenue growth of the breast implant market across the world.

Scope of the Report

As per the scope of this report, breast implants are medical devices that are used to augment the size of breasts, either for cosmetic applications or reconstruction purposes, to correct a congenital abnormality. The procedure involves the usage of breast implants, in order to enhance and improve the size of the breasts. There is an increase in the demand for breast augmentation techniques, globally, that helps in fueling the demand for breast implants in the market.

Key Market Trends

Silicone Implant is the Segment by Drug Class is expected to be Fastest Growing Segment Over the Forecast Period

Silicone gel-filled implants are the silicone shells filled with a plastic gel (silicone). Silicone implants can be inserted through an axillary incision but are not ideal when compared to other locations. Breast implant manufacturers charge around USD 1,000 more for silicone implants than they do for saline. Additionally, it is recommended that women with silicone implants have an MRI three years after their initial surgery and every two years after that. This is the only way to detect ruptures in the implant, which is often not covered by health insurance policies. The silicone gel-filled breast implants are approved for breast augmentation in women of age 22 or older and for breast reconstruction in women of any age. They are also used in revision surgeries, in order to correct or improve the result of an original surgery. Over the last 20 years, significant advances have been made to silicone gel implants. In fact, now surgeons are implanting the 7th and 8th generation of silicone breast implants. The newest silicone implants have a slightly higher fill (96% fill versus the previous generation's 85% fill) and more cross-linking of the silicone molecules, increasing the stiffness or cohesiveness of breast implants. These advances have helped in the growth of silicone breast implants.

North America is Expected to Dominate the Market

North America is found to hold a major share for the Breast Implant Market and is expected to show a similar trend over the forecast period, without significant fluctuations. The major factors contributing to the growth of the market in the United States is the large demand for breast augmentation, coupled with the greater cost of the devices. Breast augmentation is the most popular cosmetic procedure that was being performed in the country, with around 290,467 patients opting for the surgery, according to new statistics released by the American Society of Plastic Surgeons. According to the American Society of Plastic Surgeons, in 2017 there were around 27,507 breast implant removals (augmentation patients only) performed. Thus, such a huge number of cases is expected to drive the growth of the breast implant market. For example, as per the Breastcancer.org, estimates in 2019, 268,600 new cases of invasive breast cancer are expected to be diagnosed in women along with 62,930 new cases of non-invasive breast cancer, in the United States. According to the American Society of Plastic Surgeons, in 2016, the average cost of breast augmentation surgery was USD 3,719 in the country. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of small and large market players. Some of the market players are Allergan Plc, Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson), POLYTECH Health & Aesthetics GmbH, Shanghai Kangning Medical Supplies Ltd, and Sientra Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Breast Cancer
    • 4.2.2 Increasing Number of Breast Augmentation Procedures
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Post Complications and Risks Associated with Breast Implants
    • 4.3.2 High Cost of Breast Implants
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Silicone Implant
    • 5.1.2 Form-stable Implant
    • 5.1.3 Saline Implant
    • 5.1.4 Structured Saline Implant
  • 5.2 By Application
    • 5.2.1 Reconstructive Surgery
    • 5.2.2 Cosmetic Surgery
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Cosmetology Clinic
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan PLC
    • 6.1.2 Establishment Labs SA
    • 6.1.3 GC Aesthetics
    • 6.1.4 Groupe Sebbin SAS
    • 6.1.5 Laboratories Arion
    • 6.1.6 Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson)
    • 6.1.7 POLYTECH Health & Aesthetics GmbH
    • 6.1.8 Shanghai Kangning Medical Supplies Ltd
    • 6.1.9 Sientra Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top